KR102687638B1 - 이온화 방사선 조사 멸균된 박테리아 미니세포 기반 생물 약제 - Google Patents

이온화 방사선 조사 멸균된 박테리아 미니세포 기반 생물 약제 Download PDF

Info

Publication number
KR102687638B1
KR102687638B1 KR1020237024744A KR20237024744A KR102687638B1 KR 102687638 B1 KR102687638 B1 KR 102687638B1 KR 1020237024744 A KR1020237024744 A KR 1020237024744A KR 20237024744 A KR20237024744 A KR 20237024744A KR 102687638 B1 KR102687638 B1 KR 102687638B1
Authority
KR
South Korea
Prior art keywords
minicells
minicell
composition
spp
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020237024744A
Other languages
English (en)
Korean (ko)
Other versions
KR20230111275A (ko
Inventor
매튜 제이. 지아칼론
개리 에이치. 워드
Original Assignee
벡션 테라퓨틱스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 벡션 테라퓨틱스 엘엘씨 filed Critical 벡션 테라퓨틱스 엘엘씨
Publication of KR20230111275A publication Critical patent/KR20230111275A/ko
Application granted granted Critical
Publication of KR102687638B1 publication Critical patent/KR102687638B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
KR1020237024744A 2015-08-04 2016-08-03 이온화 방사선 조사 멸균된 박테리아 미니세포 기반 생물 약제 Active KR102687638B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562200903P 2015-08-04 2015-08-04
US62/200,903 2015-08-04
KR1020187006127A KR102558941B1 (ko) 2015-08-04 2016-08-03 박테리아 미니세포 기반 생물 약제의 이온화 방사선 조사 멸균 및 그 사용방법
PCT/US2016/045400 WO2017024059A1 (en) 2015-08-04 2016-08-03 Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020187006127A Division KR102558941B1 (ko) 2015-08-04 2016-08-03 박테리아 미니세포 기반 생물 약제의 이온화 방사선 조사 멸균 및 그 사용방법

Publications (2)

Publication Number Publication Date
KR20230111275A KR20230111275A (ko) 2023-07-25
KR102687638B1 true KR102687638B1 (ko) 2024-07-22

Family

ID=57943608

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020187006127A Active KR102558941B1 (ko) 2015-08-04 2016-08-03 박테리아 미니세포 기반 생물 약제의 이온화 방사선 조사 멸균 및 그 사용방법
KR1020237024744A Active KR102687638B1 (ko) 2015-08-04 2016-08-03 이온화 방사선 조사 멸균된 박테리아 미니세포 기반 생물 약제

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020187006127A Active KR102558941B1 (ko) 2015-08-04 2016-08-03 박테리아 미니세포 기반 생물 약제의 이온화 방사선 조사 멸균 및 그 사용방법

Country Status (7)

Country Link
US (3) US10124024B2 (enExample)
EP (1) EP3331575A4 (enExample)
JP (2) JP6824960B2 (enExample)
KR (2) KR102558941B1 (enExample)
CN (2) CN113577323B (enExample)
AU (1) AU2016301302B2 (enExample)
WO (1) WO2017024059A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018098163A1 (en) 2016-11-23 2018-05-31 Vaxiion Therapeutics, Llc Immunomodulatory & oncolytic minicells and methods of use
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
US11649265B2 (en) 2017-04-28 2023-05-16 Agrospheres, Inc. Compositions and methods for the encapsulation and scalable delivery of agrochemicals
US11812743B2 (en) 2017-09-25 2023-11-14 Agrospheres, Inc. Compositions and methods for scalable production and delivery of biologicals
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN110514772A (zh) * 2019-08-09 2019-11-29 中国医学科学院基础医学研究所 透明肾细胞癌代谢标志物在肾细胞癌早期筛查和诊断产品中的应用
US20230044257A1 (en) * 2019-12-23 2023-02-09 Agrospheres, Inc. Compositions and methods for enhanced uptake of active ingredients for animal health and nutrition
WO2021237091A1 (en) * 2020-05-21 2021-11-25 Coherus Biosciences, Inc. Systems and methods for producing sterile injection devices
JPWO2022215495A1 (enExample) * 2021-04-08 2022-10-13
CN117618602A (zh) * 2023-12-18 2024-03-01 苏州尔生生物医药有限公司 一种负载癌细胞裂解物组分的癌症粒子疫苗的终端灭菌方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014055682A1 (en) 2012-10-02 2014-04-10 Vaxiion Therapeutics, Inc. Immunomodulatory minicells and methods of use

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58131920A (ja) 1982-01-29 1983-08-06 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4895724A (en) 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
WO1999059643A2 (en) 1998-05-20 1999-11-25 Sdg, Inc. Liposomal delivery complex
US7396822B2 (en) 2001-05-24 2008-07-08 Vaxiion Therapeutics, Inc. Immunogenic minicells and methods of use
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
US20030166099A1 (en) 2001-06-05 2003-09-04 Sabbadini Roger A. Minicells comprising membrane proteins
US20030207833A1 (en) 2002-02-25 2003-11-06 Neil Berkley Pharmaceutical compositions with minicells
ATE502300T1 (de) 2002-12-26 2011-04-15 Nitto Boseki Co Ltd Immunoassay-verfahren
CA2516942A1 (en) * 2003-02-04 2004-08-19 Mcmaster University Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
AU2004297414C1 (en) 2003-12-09 2009-06-25 Engeneic Molecular Delivery Pty Ltd Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
WO2005058333A1 (de) * 2003-12-18 2005-06-30 Owen Holding Ltd Methode zur gewinnung eines biologisch aktiven mit elektroschock behandelten blutserums und seine verwendung
EP2992901B1 (en) 2004-02-02 2019-10-23 EnGeneIC Molecular Delivery Pty Ltd Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
US8772013B2 (en) 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
WO2006055024A2 (en) 2004-04-05 2006-05-26 Vaxiion Therapeutics, Inc. Minicells as vaccines
PL2386640T3 (pl) 2004-08-26 2015-08-31 Engeneic Molecular Delivery Pty Ltd Dostarczanie funkcjonalnych kwasów nukleinowych do komórek ssaczych za pośrednictwem nienaruszonych minikomórek pochodzenia bakteryjnego
US9358292B2 (en) * 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
WO2009012493A2 (en) 2007-07-19 2009-01-22 The Board Of Regents Of The University Of Oklahoma H-antigen binding polypeptides and methods of use
US8236538B2 (en) * 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
CN105483067A (zh) 2008-06-25 2016-04-13 瓦克星治疗有限责任公司 可调型基因自杀机制组合物和方法
EP2356235A1 (en) 2008-11-14 2011-08-17 Marina Biotech, Inc. E. coli mediated gene silencing of beta-catenin
EP2675474B1 (en) * 2011-02-15 2019-01-16 Vaxiion Therapeutics, LLC Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
CN102349978A (zh) * 2011-10-27 2012-02-15 天津中新药业集团股份有限公司达仁堂制药厂 生血丸在制备预防低剂量电离辐射致细胞损伤药物中的应用
WO2018098163A1 (en) * 2016-11-23 2018-05-31 Vaxiion Therapeutics, Llc Immunomodulatory & oncolytic minicells and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014055682A1 (en) 2012-10-02 2014-04-10 Vaxiion Therapeutics, Inc. Immunomodulatory minicells and methods of use

Also Published As

Publication number Publication date
CN108348624B (zh) 2021-07-27
WO2017024059A8 (en) 2017-06-29
JP7568519B2 (ja) 2024-10-16
KR102558941B1 (ko) 2023-07-21
KR20230111275A (ko) 2023-07-25
AU2016301302A1 (en) 2018-03-08
EP3331575A1 (en) 2018-06-13
CN113577323B (zh) 2024-02-20
US20180153942A1 (en) 2018-06-07
JP2018522036A (ja) 2018-08-09
KR20180056642A (ko) 2018-05-29
US10124024B2 (en) 2018-11-13
US20230321159A1 (en) 2023-10-12
US12427172B2 (en) 2025-09-30
JP6824960B2 (ja) 2021-02-03
CN113577323A (zh) 2021-11-02
CN108348624A (zh) 2018-07-31
AU2016301302B2 (en) 2023-01-12
WO2017024059A1 (en) 2017-02-09
US20190282629A1 (en) 2019-09-19
US11564953B2 (en) 2023-01-31
EP3331575A4 (en) 2019-03-27
JP2021059600A (ja) 2021-04-15

Similar Documents

Publication Publication Date Title
US12427172B2 (en) Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
US10919942B2 (en) Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
US20220054585A1 (en) Immunomodulatory & oncolytic minicells and methods of use
US20250339518A1 (en) Dual sting/rig-i agonist oncolytic minicells as in situ immunization agents and methods of use

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20230719

Application number text: 1020187006127

Filing date: 20180302

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20230808

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230828

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20240215

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240423

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240718

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240718

End annual number: 3

Start annual number: 1

PG1601 Publication of registration